WA
GILD icon

WPG Advisers’s Gilead Sciences GILD Stock Holding History

WPG Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
871
+30
+4% +$3.95K 0.06% 181
2026
Q1 		$117K Sell
841
-29
-3% -$4.06K 0.09% 129
2025
Q4 		$107K Sell
870
-5
-0.6% -$608 0.08% 155
2025
Q3 		$97.1K Sell
875
-48
-5% -$5.46K 0.08% 167
2025
Q2 		$102K Sell
923
-45
-5% -$4.79K 0.09% 153
2025
Q1 		$108K Buy
968
+219
+29% +$22.6K 0.1% 151
2024
Q4 		$69.2K Buy
+749
New +$67.4K 0.06% 225

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

WPG Advisers's GILD Position: Q2 2026 in Review

WPG Advisers increased its Gilead Sciences (GILD) stake by 3.6% in Q2 2026, buying an estimated $3.95K and bringing the position to 871 shares worth $110K. The position accounts for 0.06% of the portfolio, ranked #181.

WPG Advisers first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $117K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • WPG Advisers held 871 shares of Gilead Sciences worth $110K as of Q2 2026.
  • WPG Advisers bought 30 Gilead Sciences shares in Q2 2026, an estimated $3.95K.
  • Gilead Sciences made up 0.06% of WPG Advisers's portfolio in Q2 2026, its #181 holding.
  • WPG Advisers first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Gilead Sciences position peaked at $117K in Q1 2026.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.